From the Institute of Public Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Epidemiology. 2023 Sep 1;34(5):712-720. doi: 10.1097/EDE.0000000000001642. Epub 2023 Jun 30.
The Berlin-based B_PROUD study was designed to assess the effect of mobile stroke unit (MSU) dispatch among ischemic stroke and transient ischemic attack (TIA) patients without contraindications to reperfusion treatments. However, a large proportion of patients for whom the MSU was dispatched did not ultimately receive MSU care. We estimated the causal effect of additional MSU care on 3-month functional outcomes among B_PROUD patients for whom an MSU was dispatched.
We used data from the B_PROUD study (1 February 2017-8 May 2019). Given the presence of exposure-outcome unmeasured confounding, we used the front-door formula to identify the distribution of modified Rankin scale (mRS) outcomes under two hypothetical interventions: (1) receiving additional MSU care and (2) only receiving conventional care. We considered the time from dispatch to thrombolysis as the full mediator and adjusted for exposure-mediator and mediator-outcome confounding. We used a parametric estimator to estimate the common odds ratio (cOR) and 95% bootstrapped confidence intervals (CI).
We included in total 768 ischemic stroke/TIA patients with MSU dispatch. The MSU was canceled for 180 (23%) patients, whereas 588 (77%) received MSU care. The unadjusted association between the care group and mRS favored conventional care (cOR = 1.7; 95% CI = 1.2, 2.3); however, after applying the front-door formula, the mRS distribution favored MSU care (cOR = 0.88; 95% CI = 0.81, 0.96).
Receiving MSU care was associated with better functional outcomes than conventional care only, compatible with the hypothesized beneficial effect of MSU care on poststroke outcomes, among stroke and TIA patients without contraindications to reperfusion treatments.
柏林的 B_PROUD 研究旨在评估移动卒中单元(MSU)调度对无再灌注治疗禁忌的缺血性卒中和短暂性脑缺血发作(TIA)患者的影响。然而,很大一部分被 MSU 调度的患者最终并未接受 MSU 护理。我们估计了在被 MSU 调度的 B_PROUD 患者中,额外的 MSU 护理对 3 个月功能结局的因果效应。
我们使用了 B_PROUD 研究的数据(2017 年 2 月 1 日至 2019 年 5 月 8 日)。鉴于存在暴露-结局未测量混杂因素,我们使用前门公式确定了两种假设干预下的改良 Rankin 量表(mRS)结局分布:(1)接受额外的 MSU 护理和(2)仅接受常规护理。我们将从调度到溶栓的时间视为完全中介,并调整了暴露-中介和中介-结局混杂因素。我们使用参数估计器来估计共同比值比(cOR)和 95% bootstrap 置信区间(CI)。
我们共纳入了 768 例有 MSU 调度的缺血性卒中和 TIA 患者。180 例(23%)患者的 MSU 被取消,而 588 例(77%)患者接受了 MSU 护理。护理组与 mRS 的未调整关联有利于常规护理(cOR=1.7;95%CI=1.2,2.3);然而,在前门公式应用后,mRS 分布有利于 MSU 护理(cOR=0.88;95%CI=0.81,0.96)。
在无再灌注治疗禁忌的卒中/TIA 患者中,与常规护理相比,接受 MSU 护理与更好的功能结局相关,这与 MSU 护理对卒中后结局的假设有益效应一致。